KGN — Wound Dressing With Animal-Derived Material(S) Class U
FDA product code KGN covers "Wound Dressing With Animal-Derived Material(S)", a Class U medical device. Submissions are reviewed by the SU panel. Devices under this code are implants. At least 20 recent 510(k) clearances have been granted under this product code.
Classification details
- Product Code
- KGN
- Device Class
- Class U
- Submission Type
- 510(k)
- Review Panel
- SU
- Implant
- Yes
Recent 510(k) clearances
| K-Number | Applicant | Device Name | Date |
|---|---|---|---|
| K260058 | Kerecis Limited | Kerecis Express (50250) | Oct 30, 2026 |
| K260920 | Berkeley Advanced Biomaterials | Accelagen Advanced Surgical Collagen Matrix, 1cc (CG-01AA); Accelagen Advanced… | Oct 22, 2026 |
| K260530 | Mlm Biologics | epi-ConneKt Wound Matrix | Oct 15, 2026 |
| K260652 | Covalon Technologies | ColActive Plus | Sep 9, 2026 |
| K260711 | Berkeley Advanced Biomaterials | Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix… | Aug 27, 2026 |
| K260596 | Ventris Medical | Collagen Wound Powder | Jul 2, 2026 |
| K260669 | Aroa Biosurgery | Endoform Dermal Template | Jun 24, 2026 |
| K253521 | Ecm Therapeutics | ECMT-100 WMD | Jun 18, 2026 |
| K253204 | Biotissue Holdings | Catalyze | Jun 5, 2026 |
| K254034 | Roosin Medical Co | Roosin Collagen Powder | Jun 3, 2026 |
| K253974 | Roosin Medical Co | Roosin Collagen Dressing | Jun 3, 2026 |
| K261224 | Medskin Solutions Dr. Suwelack | MatriDerm | May 14, 2026 |
| K260532 | Geistlich Pharma | Derma-Gide | Mar 19, 2026 |
| K260218 | Lacerta Life Sciences | LacertaMatrix | Feb 19, 2026 |
| K253140 | Ovigenex | CollOvine Wound Powder | Feb 10, 2026 |
| K251323 | Geistlich Pharma | Device 104 Particulate | Jan 22, 2026 |
| K253339 | Stimlabs | Theracor | Dec 22, 2025 |
| K252673 | Lacerta Life Science | LacertaMatrix | Dec 22, 2025 |
| K250864 | Medskin Solutions Dr. Suwelack | MatriDerm pluS+ Bi-Layer | Dec 19, 2025 |
| K242100 | Maxigen Biotech | SurgiAid Collagen Wound Dressing (HA) | Oct 16, 2025 |